Market Overview
The global Epitranscriptomics Market was valued at approximately USD 0.8 billion in 2025 and is projected to reach USD 3.0 billion by 2035, registering a CAGR of 14.3% during 2025–2035, according to MarketGenics market estimates. Epitranscriptomics is the study of chemical modifications to RNA that influence gene expression, RNA stability, splicing, and protein production...
Market Overview
The global Gene Therapy for Ultra-Rare Diseases Market is gaining attention as advances in genetic medicine create new possibilities for treating rare inherited conditions that often have limited treatment options. One published market estimate values this specialized market at USD 0.3 billion in 2025 and projects it to reach USD 0.7 billion by 2035, representing a CAGR of 8.4%...
Market Overview
The global Therapeutic Radiopharmaceuticals Market was valued at approximately USD 7.6 billion in 2025 and is projected to reach USD 13.9 billion by 2035, registering a CAGR of 6.2% during 2025–2035, according to one market estimate. The market focuses on radioactive medicines used to treat diseases by delivering radiation to specific cells or tissues, particularly cancer...
Market Overview
The global Regenerative Medicine Market was valued at USD 31.7 billion in 2025 and is projected to reach USD 218.6 billion by 2035, registering a CAGR of 21.3% during 2025–2035. Regenerative medicine focuses on repairing, replacing, or regenerating damaged cells, tissues, and organs to restore biological function. The market includes cell therapy, gene therapy, tissue...
Market Overview
The global Self-Amplifying RNA (saRNA) Market was valued at approximately USD 100 million in 2025 and is projected to grow at a CAGR of 18.6% during 2025–2035, according to the MarketGenics market report. Self-amplifying RNA is an advanced RNA technology that enables genetic instructions to replicate within cells, allowing them to produce a target protein or antigen from a...
Market Overview
The global Sterile Injectable Outsourcing Market is experiencing strong growth as pharmaceutical and biotechnology companies increasingly rely on specialized contract development and manufacturing organizations (CDMOs) for sterile drug production. According to Grand View Research, the closely related sterile injectable contract manufacturing market was valued at USD 15.5 billion...
Market Overview
The global Neoantigen & Personalized Cancer Vaccines Market is gaining momentum as advances in precision oncology enable the development of cancer vaccines tailored to the genetic characteristics of individual tumors. One published estimate values the broader personalized cancer vaccine market at USD 0.6 billion in 2025, with a projection of USD 5.5 billion by 2035,...
Market Overview
As per MarketGenics, the global Oral Biologics & Peptide Stabilization Market was valued at USD 2.1 billion in 2025 and is projected to reach USD 5.8 billion by 2035, registering a CAGR of 10.7% during 2025–2035. The market focuses on technologies, formulations, and stabilization methods that help protect biologic medicines and peptide-based therapies from degradation...
Market Overview
The global Therapeutics & Biotech Niche Areas Market is valued at USD 173.6 billion in 2025 and is projected to reach USD 558.7 billion by 2035, registering a CAGR of 12.4% during 2025–2035, according to MarketGenics market estimates. The market encompasses specialized therapeutic and biotechnology segments, including oncology, rare diseases, immunology and...
Market Overview
The global Weight-Loss Pill Market is expanding as demand increases for pharmaceutical treatments and oral products designed to support weight management. The market’s size depends on whether it includes prescription weight-loss medications alone or also over-the-counter dietary supplements. For the narrower prescription weight-loss pills market, one industry estimate...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek